RecallRadar

FDA Drug recall D-1540-2022

PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of…

On 2022-09-21 the FDA classified a Class I recall of PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of… by Pfizer, citing presence of particulate matter.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1540-2022
ClassificationClass I
Statusterminated
Initiated2022-08-22
Published2022-09-21
Last updated2026-09-13 11:52 UTC
CompanyPfizer
DistributionUS

Product

PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Reason

Presence of particulate matter

Identifiers

ndc0409-4699-50
ndc0409-4699-30
ndc0409-4699-53
ndc0409-4699-33
ndc0409-4699-54
ndc0409-4699-24
ndc0409-6010-02
ndc0409-6010-25
ndc0409-1511-97
ndc0409-1511-98
ndc0409-0501-97
ndc0409-0501-98
ndc0409-0010-97
ndc0409-0010-98
code_infoLot#: EA7470, Exp 6/1/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1540-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.